Table 4.
Neurological symptoms at primary presentation in 37 HIV-infected individuals with CM and after 4 months and 3 years after CM
Category, parameter | Disease presentation (n=37) | 4-month follow-up (n=16) | 3-year follow-up (n=21) |
---|---|---|---|
Neurological symptoms | |||
Cognitive deficits | 15 (41) | 1 (6) | 1 (5) |
Coordination disturbance | 7 (19) | 2 (12) | 0 (0) |
Speech disturbance | 3 (8) | 2 (12) | 0 (0) |
Visual impairment | 5 (13) | 1 (6) | 0 (0) |
Facial palsy | 1 (3) | 0 (0) | 0 (0) |
Limb paresis | 4 (11) | 2 (12) | 0 (0) |
Sensory affection | 0 (0) | 0 (0) | 0 (0) |
Seizures | 4 (11) | 0 (0) | 0 (0) |
Need help in everyday life | 2 (5) | 3 (19) | 0 (0) |
Headache | 27 (73) | 7 (44) | 0 (0) |
Fever | 29 (78) | 2 (12) | 0 (0) |
Nausea and vomiting | 16 (43) | 4 (25) | 0 (0) |
Neck stiffness | 12 (32) | 0 (0) | 0 (0) |
Photophobia | 3 (8) | 0 (0) | 0 (0) |
Papilledema | 2 (5) | 0 (0) | 0 (0) |
Status at follow-up | |||
Progression of neurological symptoms | – | 2 (12) | 0 (0) |
Unchanged neurological symptoms | – | 1 (6) | 0 (0) |
Improvement of neurological symptoms | – | 13 (81) | 1 (5) |
Return to pre-CM level of activity | – | 10 (62) | 18 (86) |
Note: Data presented as n (%) of individuals.
Abbreviation: CM, cryptococcal meningitis.